Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 3/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78219 | 1.00 | SIGMAR1 (0.53) | SIGMAR1HTR2AIDO1PAMMAOB | |
| Benzene SCHEMBL1226215 | 1.00 | SIGMAR1 (0.53) | SIGMAR1HTR2AIDO1PAMMAOB | |
| SCHEMBL28490848 | 1.00 | SIGMAR1 (0.53) | SIGMAR1HTR2AIDO1PAMMAOB | |
| Benzene SCHEMBL1226219 | 1.00 | SIGMAR1 (0.53) | SIGMAR1HTR2AIDO1PAMMAOB | |
| Anthracene SCHEMBL28105538 | 0.90 | TLR8 (0.47) | SIGMAR1HTR2AIDO1PAMRELA | |
| SCHEMBL28386776 | 0.87 | CA1 (0.46) | SIGMAR1HTR2ARELAHDAC3HDAC4 | |
| SCHEMBL27816694 | 0.87 | HTR2A (0.49) | SIGMAR1HTR2AIDO1PAMRELA | |
| SCHEMBL15573543 | 0.86 | SIGMAR1 (0.50) | SIGMAR1HTR2AIDO1PAMMAOB | |
| SCHEMBL1295478 | 0.86 | SIGMAR1 (0.50) | SIGMAR1HTR2AIDO1PAMMAOB | |
| SCHEMBL22082 | 0.86 | SIGMAR1 (0.50) | SIGMAR1HTR2AIDO1PAMMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121575410-A | Phosphorus-free high-temperature corrosion inhibitor and preparation method thereof | 金浦新材料股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-112710743-B | Separation and detection method for impurities in carbonate solvent and application thereof | 山东海科新源材料科技股份有限公司 | 2022-08-19 | — | — | CN | claimed |
| US-9242918-B2 | Dehydrogenation processes and phenol compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-01-26 | — | — | US | claimed |
| US-20130296614-A1 | Dehydrogenation Processes and Phenol Compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-11-07 | — | — | US | claimed |
| WO-2012036819-A1 | DEHYDROGENATION PROCESS OF CYCLOHEXANONE AND PHENOL COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-22 | — | — | WO | claimed |
| EP-2280075-A1 | Biocatalyst for catalytic hydroamination | BASF SE (DE) | 2011-02-02 | — | — | EP | claimed |
| US-7776975-B2 | Aqueous polymerization process for preparing an aqueous polymer dispersion | ROHM AND HAAS COMPANY (US) | 2010-08-17 | — | — | US | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| EP-1288235-B1 | Agents for the improvement of the vulcanisation behaviour in the preparation of grafted or crosslinked polymers and filled resins | EVONIK DEGUSSA GMBH (DE) | 2008-02-20 | — | — | EP | claimed |
| US-6864323-B2 | Composition for improving scorch conditions in the preparation of grafted and/or crosslinked polymers and of filled plastics | DEGUSSA AG (DE) | 2005-03-08 | — | — | US | claimed |
| US-20030114604-A1 | Composition for improving scorch conditions in the preparation of grafted and/or crosslinked polymers and of filled plastics | DEGUSA AG (DE) | 2003-06-19 | — | — | US | claimed |
| CN-121575410-A | Phosphorus-free high-temperature corrosion inhibitor and preparation method thereof | 金浦新材料股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-RE30812-E | ANTIARRHTHMIA AGENTS | MEAD JOHNSON & COMPANY (US) | 1981-12-01 | — | — | US | disclosed |
| US-4012305-A | DIMERIZATION OF STYRENES | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-03-15 | — | — | US | disclosed |
| US-3998894-A | DIMERIZATION AND CYCLIZATION OF A STYRENE AND A HAL GENO-STYRENE | BASF AKTIENGESELLSCHAFT (DT) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296614-A1 | Dehydrogenation Processes and Phenol Compositions | HPD, CYP2E1, CYP2J2 | SIGMAR1 1686/4885HTR2A 1194/4885IDO1 868/4885 |
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | SIGMAR1 4688/4885HTR2A 3731/4885IDO1 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.